snris | CARLAT PUBLISHING

Psychopharm Commandment #6: MAOIs

March 20, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

MAOIs rank high in efficacy and are pretty well tolerated too, as long as you watch for two critical interactions.

10 Psychopharm Commandments: Med Withdrawal

September 26, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

When to stop meds quickly, and when to do it slowly, in #2 of our 10 Commandment series.

Treating Anxiety Disorders in Children: The New AACAP Clinical Practice Guideline

March 24, 2022

Reese Abright, MD

Reese Abright, MD

Director, Division of Child and Adolescent Psychiatry and Fellowship Training Program in Child and Adolescent Psychiatry, Mount Sinai Services - New York City Health + Hospitals/Elmhurst. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai.

Dr. Abright has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

There is a new process for sorting and consolidating treatment recommendations: Clinical Practice Guidelines are the new gold standard. We spoke with Dr. A. Reese Abright about the CPG on anxiety disorders to help you understand where the state of the art is for treating the usual disorders that come up in our clinical practice settings.

Comparison of GI Side Effects of Antidepressants

August 3, 2021

Jesus Ligot, MD.

Jesus Ligot, MD. Dr. Ligot has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Modern antidepressants are ranked by their risk of GI side effects, with a few surprises baked in.

SSRIs vs SNRIs in Pediatric Anxiety Disorders: Which Are More Tolerable?

July 14, 2021

John Raiss, MD.

John Raiss, MD. Dr. Raiss has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Which class of medication performs better for treating anxiety or OCD in children and adolescents, SSRI’s or SNRI’s? This study sorts through the comparative efficacy vs. side effects so that you can better decide how to help your patients.